MedPath

Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer

Not Applicable
Conditions
unresectable pancreatic cancer
Registration Number
JPRN-UMIN000020809
Lead Sponsor
ara Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

the presence of a contraindication for magnetic resonance imaging

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath